Parkinson's Disease Drug Market is segmented based on drug types, distribution channel, end users, applications, and
region. Drug types such as Anticholinergics (Benztropine or Trihexyphenidyl), Levodopa/Carbidopa, COMT-Inhibitors
(Entacapone, Tolcapone), Amantadine, Dopamine Agonists (Ropinirole or Pramipexole), MAO-B Inhibitors (Selegiline,
Rasagiline), Apomorphine, and others classify this market.
Distribution channels such as Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, and others classify
Parkinson's Disease Drug Market. End users such as Clinics, Hospitals, and others classify this industry. Applications
into Above 65 Years Old, 40-65 Years Old, and Under 40 Years Old classify Parkinson's Disease Drug Industry. This
Market is segmented geographically Americas (North America, Latin America), Europe (Eastern Europe, Western
Europe), Asia Pacific, Latin America, Middle East and Africa.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/Parkinson-s-disease-pd-drug-market/request-sample
Globally, North America accounts for the largest market share of Parkinson's Disease Drug Market and is estimated to
lead the overall market in the upcoming years. The reason being, developed healthcare infrastructure, use of enhanced
technology, developed R&D, and good reimbursement policies. Europe and Asia Pacific follow suit. On the other hand,
Europe accounts for the second largest market share of this industry. This is mainly due to rising R&D efforts by the
prominent players.
The key players of Parkinson's Disease Drug Industry are Valeant Pharmaceuticals, GSK, US WorldMeds, Novartis,
StadaArzneimittel, BoehringerIngelheim, Orion, Teva Pharmaceutical, Apokyn, Abbvie, Valeant, Merck, Lundbeck,
Akorn, Hoffmann-La Roche, Kyowa Hakko Kirin Pharma, Endo Pharmaceuticals, Astellas Pharma, and
DesitinArzneimittel. These players are concentrating on inorganic growth to sustain themselves amongst fierce
competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Market Segment:
The major manufacturers covered in this report
• Merck
• Akorn
• GSK
• Novartis
• Boehringer Ingelheim